What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review

BACKGROUND: Granulomatous disease is reported in at least 8–20% of patients with common variable immunodeficiency (CVID). Granulomatous disease mainly affects the lungs, and is associated with significantly higher morbidity and mortality. In half of patients with granulomatous disease, extrapulmonar...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Immunol
Glavni autori: van Stigt, Astrid C., Dik, Willem A., Kamphuis, Lieke S. J., Smits, Bas M., van Montfrans, Joris M., van Hagen, P. Martin, Dalm, Virgil A. S. H., IJspeert, Hanna
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Immunology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7773704/
https://ncbi.nlm.nih.gov/pubmed/33391274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.606389
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items